Extract notice to the Minister

JAMP Lisdexamfetamine

Common name / Subject : lisdexamfétamine (dimésylate de)
Name of the manufacturer : Jamp
Form :
Dosage :

Indication :

INESSS' Recommendation
Inscription - Avec conditions

Minister's decisions
Inscrire aux listes des
médicaments - Médicament
d'exception

Evaluation published on September 25, 2025

Subscribe to our newsletter now

Subscription